1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018
2. Using PARP inhibitors in the treatment of patients with ovarian cancer;Kurnit;Curr Treat Options Oncol,2018
3. Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer;Moore;N Engl J Med,2018
4. Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer;Ledermann;N Engl J Med,2012
5. Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial;Pujade-Lauraine;Lancet Oncol,2017